Bionano Genomics Total Assets

Bionano Genomics (BNGO) currently reports a total assets of $48M as of June 2026. That compares with $76M in the prior-year period — down 37.4% year over year. Use the charts on this page to explore Bionano Genomics's total assets history and peer comparisons.

Bionano Genomics's total assets decreased from $76M to $48M — a 37.4% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Bionano Genomics reported $48M in total assets as of June 2026. That compares with $76M in the prior-year period — down 37.4% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total assets of $48M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Bionano Genomics, and consider following BNGO for alerts when major investors trade the stock.

Bionano Genomics is classified in the Healthcare sector. On total assets, it currently shows $48M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing BNGO with unrelated industries.